XML 51 R65.htm IDEA: XBRL DOCUMENT v3.2.0.727
Guarantor Infromation (Cash Flows) (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities $ 24,220 $ 55,900
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (25,620) (46,464)
Proceeds from Sale of Productive Assets 638 2,523
Proceeds from derivative instruments (7,804) (194)
Insurance recoveries 0 2,834
Net cash used in investing activities (32,786) (41,301)
Cash flow from financing activities:    
Repayments to affiliates 0  
Loans from (repayments to) affiliates   0
Short-term debt borrowings 4,506 (1,019)
Revolving Facility borrowings 74,000 209,000
Revolving Facility reductions (66,000) (205,000)
Principal payments on long term debt (67) (126)
Supply chain financing 0 (9,455)
Proceeds from exercise of stock options 0 2,813
Purchase of treasury shares (63) (435)
Revolving Facility refinancing (2,722) (2,636)
Other (2,850) 918
Net cash provided by financing activities 6,804 (5,940)
Net (decrease) increase in cash and cash equivalents (1,762) 8,659
Effect of exchange rate changes on cash and cash equivalents (1,283) 181
Cash and cash equivalents at beginning of period 17,550 11,888
Cash and cash equivalents at end of period 14,505 20,728
Parent Company [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (7,355) (11,480)
Cash flow from investing activities:    
(Loans to) repayments from affiliates 7,418 8,184
Capital expenditures 0 0
Proceeds from Sale of Productive Assets 0  
Proceeds from derivative instruments 0 0
Insurance recoveries 0 0
Net cash used in investing activities 7,418 8,184
Cash flow from financing activities:    
Repayments to affiliates 0  
Loans from (repayments to) affiliates 0 0
Short-term debt borrowings 0 0
Revolving Facility borrowings 0 0
Revolving Facility reductions 0 0
Principal payments on long term debt 0 0
Supply chain financing 0 0
Proceeds from exercise of stock options 0 2,813
Purchase of treasury shares (63) (435)
Revolving Facility refinancing 0 0
Other 0 918
Net cash provided by financing activities (63) 3,296
Net (decrease) increase in cash and cash equivalents 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Guarantor Subsidiaries [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 22,992 33,155
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (16,994) (31,882)
Proceeds from Sale of Productive Assets 397 0
Proceeds from derivative instruments (7,595) 74
Insurance recoveries 0 0
Net cash used in investing activities (24,192) (31,808)
Cash flow from financing activities:    
Repayments to affiliates (7,418)  
Loans from (repayments to) affiliates 0 (8,184)
Short-term debt borrowings 2,001 (23)
Revolving Facility borrowings 62,000 131,000
Revolving Facility reductions (54,000) (124,000)
Principal payments on long term debt (67) (66)
Supply chain financing 0 0
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Revolving Facility refinancing (2,691) (2,320)
Other (2,850) 0
Net cash provided by financing activities (3,025) (3,593)
Net (decrease) increase in cash and cash equivalents (4,225) (2,246)
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 5,503 4,752
Cash and cash equivalents at end of period 1,278 2,506
Non-Guarantor Subsidiaries [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 36,293 34,225
Cash flow from investing activities:    
(Loans to) repayments from affiliates 0 0
Capital expenditures (8,626) (14,582)
Proceeds from Sale of Productive Assets 241 2,523
Proceeds from derivative instruments (209) (268)
Insurance recoveries 0 2,834
Net cash used in investing activities (8,594) (9,493)
Cash flow from financing activities:    
Repayments to affiliates 0  
Loans from (repayments to) affiliates (27,710) 0
Short-term debt borrowings 2,505 (996)
Revolving Facility borrowings 12,000 78,000
Revolving Facility reductions (12,000) (81,000)
Principal payments on long term debt 0 (60)
Supply chain financing 0 (9,455)
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Revolving Facility refinancing (31) (316)
Other 0 0
Net cash provided by financing activities (25,236) (13,827)
Net (decrease) increase in cash and cash equivalents 2,463 10,905
Effect of exchange rate changes on cash and cash equivalents (1,283) 181
Cash and cash equivalents at beginning of period 12,047 7,136
Cash and cash equivalents at end of period 13,227 18,222
Consolidating Entries and Eliminations [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (27,710) 0
Cash flow from investing activities:    
(Loans to) repayments from affiliates (7,418) (8,184)
Capital expenditures 0 0
Proceeds from Sale of Productive Assets 0  
Proceeds from derivative instruments 0 0
Insurance recoveries 0 0
Net cash used in investing activities (7,418) (8,184)
Cash flow from financing activities:    
Repayments to affiliates 7,418  
Loans from (repayments to) affiliates 27,710 8,184
Short-term debt borrowings 0 0
Revolving Facility borrowings 0 0
Revolving Facility reductions 0 0
Principal payments on long term debt 0 0
Supply chain financing 0 0
Proceeds from exercise of stock options 0 0
Purchase of treasury shares 0 0
Revolving Facility refinancing 0 0
Other 0 0
Net cash provided by financing activities 35,128 8,184
Net (decrease) increase in cash and cash equivalents 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0